These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15313905)

  • 1. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
    Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
    Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
    Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
    Tieva A; Bergh A; Damber JE
    Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.
    Liu W; Wu Z; Guan M; Lu Y
    Int J Urol; 2009 Mar; 16(3):323-8. PubMed ID: 19207613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma.
    Häggström S; Bergh A; Damber JE
    Prostate; 2000 Sep; 45(1):42-50. PubMed ID: 10960841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
    Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C
    J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
    Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
    Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
    Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
    Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
    Garcia M; Fernandez-Garcia NI; Rivas V; Carretero M; Escamez MJ; Gonzalez-Martin A; Medrano EE; Volpert O; Jorcano JL; Jimenez B; Larcher F; Del Rio M
    Cancer Res; 2004 Aug; 64(16):5632-42. PubMed ID: 15313901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.